[1]
D. SUHAS, B. DEEPAK, and A. KAVITA, “REVIEW ON PHARMACOVIGILANCE STUDY OF TELMISARTAN IN HYPERTENSION PATEINTS”, Asian J Pharm Clin Res, vol. 6, no. 3, pp. 17–20, Jul. 2013.